HER2-low BC is a recently characterized subtype of HER2-negative BC with an IHC score of 1 + or 2 + /ISH negative phenotype that has led to reconsider the traditional binary classification of HER2 status according to which only patients with HER2 + BC were thought to benefit from antiHER2 therapies. Here, ERBB2 is linked to breast cancer.